Merck & Co Inc [MRK] stock prices are down -1.27% to $76.98 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MRK shares have gain 4.78% over the last week, with a monthly amount drifted -2.52%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Merck & Co Inc [NYSE: MRK] stock has seen the most recent analyst activity on May 14, 2025, when Citigroup downgraded its rating to a Neutral but kept the price target unchanged to $84 for it. Previously, Cantor Fitzgerald started tracking the stock with Neutral rating on April 22, 2025, and set its price target to $85. On February 18, 2025, downgrade downgraded it’s rating to Hold and revised its price target to $105 on the stock. TD Cowen downgraded its rating to a Hold and decreased its price target to $100 on February 10, 2025. Truist downgraded its rating to a Hold but $110 remained the price target by the analyst firm on January 08, 2025. BMO Capital Markets downgraded its rating to Market Perform for this stock on December 20, 2024, and downed its price target to $105.
The stock price of Merck & Co Inc [MRK] has been fluctuating between $73.31 and $134.63 over the past year. Currently, Wall Street analysts expect the stock to reach $99.33 within the next 12 months. Merck & Co Inc [NYSE: MRK] shares were valued at $76.98 at the most recent close of the market. An investor can expect a potential return of 29.03% based on the average MRK price forecast.
Analyzing the MRK fundamentals
The Merck & Co Inc [NYSE:MRK] reported sales of 63.78B for trailing twelve months, representing a drop of -1.20%. Gross Profit Margin for this corporation currently stands at 0.81% with Operating Profit Margin at 0.36%, Pretax Profit Margin comes in at 0.32%, and Net Profit Margin reading is 0.27%. To continue investigating profitability, this company’s Return on Assets is posted at 0.15, Equity is 0.38 and Total Capital is 0.25. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.72.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Merck & Co Inc [NYSE:MRK]’s Current Ratio is 1.41. As well, the Quick Ratio is 1.16, while the Cash Ratio is 0.34. Considering the valuation of this stock, the price to sales ratio is 3.03, the price to book ratio is 4.01 and price to earnings (TTM) ratio is 11.21.
Transactions by insiders
Recent insider trading involved Smart Dalton E. III, SVP Fin. – Global Controller, that happened on Apr 25 ’25 when 4262.0 shares were sold. Officer, DALTON SMART completed a deal on Apr 25 ’25 to buy 4262.0 shares. Meanwhile, President, U.S. Market Oosthuizen Johannes Jacobus sold 8500.0 shares on Feb 19 ’25.
